HuaBang Health's Portfolio Company BluePath Launches Data-Driven Longevity and Anti-Aging Solutions

Source: Cailian Press

【HUAPONT LIFE SCIENCES[HUAPONT LIFE SCIENCES: Participating Company Blueprint Health Provides Data-Driven Longevity and Anti-Aging Solutions] On March 25, according to Cailian Press, HUAPONT LIFE SCIENCES (002004.SZ) released an announcement on the record of investor relations activities. The company's pharmaceutical business covers integrated production of active pharmaceutical ingredients (API) and formulations, with three major API bases located in Hechuan and Changshou of Chongqing, and Hanzhong of Shaanxi. Its products span across dermatology, anti-infectives, anti-tumor drugs, and extend into the broader field of skin health. API products, mainly for export, have established long-term cooperation with international pharmaceutical companies such as Abbott, Johnson & Johnson, Eli Lilly, and Merck. The company holds a combined 13.2% stake in Pregene, a company listed on the New Third Board, through direct and indirect means, making it the third-largest shareholder, thereby laying out in cell and gene therapy drugs. The healthcare business has built a system of "basic medical care + rehabilitation medical care + longevity and anti-aging," with its brand "Blueprint Health" jointly founded with Blueprint, created by global anti-aging pioneer Bryan Johnson, providing data-driven longevity and anti-aging solutions.